StockData
Freenome, Inc. logo

Freenome, Inc. (FRNM) stock

FRNMNasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026
$9.36−0.57 (-5.69%)

Close on Nov 20, 2026Market cap $1.04BP/E –Yield –

Freenome gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

Quarterly gross profit

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$183.01M–
Q3 FY2025Sep 30, 2025$424.00K–

More Freenome figures

See a number that looks wrong?